• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EFSA J . Avian influenza overview December 2025-February 2026

tetano

Editor, Senior Moderator
EFSA J


. 2026 Mar 27;24(3):e10015.
doi: 10.2903/j.efsa.2026.10015. eCollection 2026 Mar.
Avian influenza overview December 2025-February 2026

European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC); European Union Reference Laboratory for Avian Influenza (EURL); Cyril Barbezange, Hubert Buczkowski, Mariette Ducatez, Alice Fusaro, Jose L Gonzales, Thijs Kuiken, Gražina Mirinavičiūtė, Karl Ståhl, Christoph Staubach, Olov Svartström, Calogero Terregino, Katriina Willgert, Evelyn Alarcón, Lisa Kohnle
Abstract

Between 29 November 2025 and 27 February 2026, 2514 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (406) and wild (2108) birds in 32 countries in Europe. Albeit still at high levels after the peak was reached at the beginning of the current reporting period, the weekly number of detections has since been declining. Waterfowl species were affected to a greater extent than in previous years, and more than 90% of detections in poultry were due to primary introduction from wild birds. As in previous years, a large number of backyard farms and several zoos were affected. High viral circulation in wild birds resulted in a slight increase in detections in mammals in Europe, with the first potential spillover event from wild birds to dairy cattle suggested in the Netherlands. Between 29 November 2025 and 27 February 2026, 10 cases of avian influenza virus infection were reported in humans (none of which were fatal) in two countries: Cambodia (one A(H5N1) case) and China (eight A(H9N2) cases and one A(H10N3) case). Most human cases reported exposure to poultry or a poultry environment prior to detection or onset of illness. The current high level of avian influenza virus circulation in bird populations increases the risk of human exposure to infected animals, although human infections remain rare and no instance of human-to-human transmission has been documented so far. The risk posed by avian A(H5N1) clade 2.3.4.4b influenza viruses currently circulating in Europe remains low for the general public in the European Union/European Economic Area and low-to-moderate for those occupationally or otherwise exposed to infected animals or contaminated environments.

Keywords: HPAI; avian influenza; captive birds; humans; monitoring; poultry; wild birds.

 
Back
Top